Category: Joint ventures/collaborations
-
Trial Tests Liquid Biopsy Feasibility in Lung Cancer
Companies that offer biotechnology, diagnostics, and analytics are testing liquid biopsies to make personalized diagnosis and care feasible for lung cancer patients.
-
Mayo Clinic, A.I. Company Study Covid-19 Heart Disease
A developer of software to diagnose heart disease from images with artificial intelligence is assessing Covid-19 infection patients for heart ailments with the Mayo Clinic.
-
Survey Tracking Covid-19 Mental Health Impact
A survey is underway in the U.S. to gauge the mental health impact of the Covid-19 pandemic, with data also collected with personal activity trackers.
-
Microsoft, Biotech Examine Covid-19 Immune Response
A study is enrolling home-bound participants to learn more about the response of T-cells in the immune system to SARS-CoV-2 viruses causing Covid-19 infections.
-
Oxford, AstraZeneca Partner on Covid-19 Vaccine
AstraZeneca agreed today to help develop, manufacture, and distribute a candidate vaccine to prevent Covid-19 infections designed by University of Oxford.
-
Trial to Test Many Covid-19 Lung Disease Treatments
A clinical trial designed to make quick changes to accommodate new conditions plans to assess 10 to 20 drugs for a serious lung complication from Covid-19 infections.
-
Limited Covid-19 Benefits Found for Arthritis Drug
A clinical trial testing an arthritis drug to treat Covid-19 patients shows the drug helps the most critical patients, but not others with advanced infections.
-
World Leaders Back WHO Covid-19 Plans, U.S. Absent
Several international leaders took part today in a virtual conference on accelerating and focusing World Health Organization’s efforts to combat Covid-19 infections.
-
Covid-19 Real-World Evidence System Created
Two health care data science companies are offering a system for assessing proposed treatments from health records data on patients with Covid-19 infections.
-
Digital Health Research Platform Set for Covid-19
A group of medical technology companies are forming a research platform and registry for clinical trials of Covid-19 treatments among home-bound participants.